RxSight, Inc. (RXST)
5.13
+0.23
(+4.69%)
USD |
NASDAQ |
Oct 29, 12:39
RxSight Max Drawdown (5Y) : 92.86% for Sept. 30, 2026
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| September 30, 2026 | 92.86% |
| August 31, 2026 | 92.86% |
| July 31, 2026 | 92.86% |
| June 30, 2026 | 92.86% |
| May 31, 2026 | 91.71% |
| April 30, 2026 | 90.53% |
| March 31, 2026 | 90.53% |
| February 28, 2026 | 89.66% |
| January 31, 2026 | 89.66% |
| December 31, 2025 | 89.66% |
| November 30, 2025 | 89.66% |
| October 31, 2025 | 89.66% |
| September 30, 2025 | 89.66% |
| August 31, 2025 | 89.66% |
| July 31, 2025 | 88.71% |
| June 30, 2025 | 80.29% |
| May 31, 2025 | 79.69% |
| April 30, 2025 | 78.10% |
| March 31, 2025 | 62.09% |
| February 28, 2025 | 56.12% |
| January 31, 2025 | 53.21% |
| December 31, 2024 | 48.21% |
| November 30, 2024 | 48.21% |
| October 31, 2024 | 48.21% |
| September 30, 2024 | 48.21% |
| Date | Value |
|---|---|
| August 31, 2024 | 48.21% |
| July 31, 2024 | 48.21% |
| June 30, 2024 | 48.21% |
| May 31, 2024 | 48.21% |
| April 30, 2024 | 48.21% |
| March 31, 2024 | 48.21% |
| February 29, 2024 | 48.21% |
| January 31, 2024 | 48.21% |
| December 31, 2023 | 48.21% |
| November 30, 2023 | 48.21% |
| October 31, 2023 | 48.21% |
| September 30, 2023 | 48.21% |
| August 31, 2023 | 48.21% |
| July 31, 2023 | 48.21% |
| June 30, 2023 | 48.21% |
| May 31, 2023 | 48.21% |
| April 30, 2023 | 48.21% |
| March 31, 2023 | 48.21% |
| February 28, 2023 | 48.21% |
| January 31, 2023 | 48.21% |
| December 31, 2022 | 48.21% |
| November 30, 2022 | 48.21% |
| October 31, 2022 | 48.21% |
| September 30, 2022 | 48.21% |
| August 31, 2022 | 48.21% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Precision Optics Corp., Inc. | 50.72% |
| UFP Technologies, Inc. | 48.31% |
| TransMedics Group, Inc. | 73.69% |
| Hyperfine, Inc. | 95.01% |
| Abbott Laboratories | 39.63% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -32.61 |
| Beta (5Y) | 1.151 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 63.71% |
| Historical Sharpe Ratio (5Y) | -0.331 |
| Historical Sortino (5Y) | -0.5855 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 26.79% |